PRAXIS PRECISION MEDICINES, INC. Debt Securities, Available-for-sale, Noncurrent
PRAXIS PRECISION MEDICINES, INC. (PRAX) had Debt Securities, Available-for-sale, Noncurrent of $899.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Noncurrent $899.08M.
- 2026-03-31: Debt Securities, Available-for-sale, Noncurrent $911.47M.
- 2025-12-31: Debt Securities, Available-for-sale, Noncurrent $568.76M.
- 2025-09-30: Debt Securities, Available-for-sale, Noncurrent $122.01M.
| Period end | Debt Securities, Available-for-sale, Noncurrent | Debt Securities, Available-for-sale, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $899.08M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $911.47M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $568.76M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $122.01M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $145.37M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $144.03M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $254.16M 10-K · filed 2026-02-19 | $76.96M 10-K · filed 2025-02-28 |
| 2024-09-30 | $54.14M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $81.95M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $35.87M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-28 | |
| 2022-03-31 | $11.93M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $31.53M 10-K · filed 2023-02-07 | |
| 2021-09-30 | $36.49M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $48.84M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $39.09M 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |